NIH Institute / Center · AR (NIAMS)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
117 funded awards, $62.3M total, FY2023-FY2025.
NIH SBIR/STTR funding decisions are made by Institutes and Centers based on portfolio priorities, NOFO scope, and program officer judgment. Historical funding patterns do not guarantee future funding.
Technology areas funded by NIAMS
Limitations
- RePORTER includes funded projects only, not unfunded applications.
- Panel sidebar reflects panels that have appeared on funded records, not future assignment.
- FOA-route status reflects verification at the timestamp shown.
Pattern read
NIAMS funded 117 records totaling $62M in the window, with a fairly even split across research tools, small-molecule therapeutics, environmental/occupational work, and medical devices for musculoskeletal applications. Median award is $307K, the lowest median among the larger ICs. The portfolio skews to earlier-stage and smaller-cap projects. STTR participation (R41 at 24) is high relative to total volume. Concentration is moderate at 10.3%. Arthritis, autoimmunity, and bone biology indications are the canonical fits; pitches without a clear musculoskeletal endpoint have not done well here historically.